FAM204CP

Across TCGA pan-cancer cohorts, FAM204CP RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated FAM204CP data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher FAM204CP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM204CP expression acts as an unfavorable survival marker, although some lineages such as STAD and BRCA show a favorable association.

CHOL, TGCT, and DLBC are the cancer types where FAM204CP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.675	<.001	90	view →
TGCT	OS	Tertile	III,IV	0.003	1.000	<.001	90	view →
DLBC	OS	Tertile	III,IV	0.172	0.907	<.001	36	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
STAD	OS	Quartile	II,III,IV	0.767	0.592	.011	22	view →
BRCA	DFS	Tertile	III,IV	1.000	0.453	.021	18	view →
COAD	OS	Tertile	II,III,IV	0.214	0.582	.006	15	view →
ESCA	DFS	Tertile	IV	0.730	0.287	.049	12	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	9	view →
READ	DFS	Tertile	II,III,IV	1.000	0.765	.021	9	view →
HNSC	DFS	Tertile	All	1.000	0.636	.018	9	view →
PCPG	DFS	Tertile	All	0.394	0.850	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

FAM204CP–CHOL (OS)

Open the CHOL breakdown →